End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer

Journal of Cancer Research and Clinical Oncology
Yingming ZhuJinming Yu

Abstract

Concerns regarding end-of-life (EOL) chemotherapy are being increasingly raised. Tumor chemosensitivity may influence the decision for aggressive chemotherapy near the EOL. Data on EOL chemotherapy in highly chemosensitive tumors, such as small cell lung cancer (SCLC), are scarce. A total of 143 SCLC decedents were consecutively included. Data about clinical factors and treatment modalities were obtained from the electronic medical records. The relationships among EOL chemotherapy, clinical features, overall survival (OS), and aggressive care were investigated. About 64% of patients had chemosensitive disease. In total, 30.8 and 16.1% of patients received EOL chemotherapy within the last 1 and 2 months of life, respectively. Younger age was associated with a higher rate of EOL chemotherapy. We determined that EOL chemotherapy was related to inferior OS not only in the entire group, but also in the chemosensitive subgroup. Furthermore, more intensive care was observed among patients who underwent EOL chemotherapy compared with those who did not. EOL chemotherapy was correlated with shorter survival and more aggressive care in patients with SCLC. More research is needed to develop indications for terminating palliative chemothera...Continue Reading

References

Nov 1, 1987·European Journal of Cancer & Clinical Oncology·G GiacconeA Calciati
Aug 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G GiacconeA Calciati
Apr 16, 2003·Annals of Internal Medicine·Ezekiel J EmanuelArlene S Ash
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natasha B LeighlMartin H N Tattersall
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robin MatsuyamaThomas J Smith
Aug 23, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·José Ferraz Gonçalves, Carmen Goyanes
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marcello Tiseo, Andrea Ardizzoni
May 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KaoD Adams
Mar 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U NäppäB Axelsson
Sep 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Braga
Jan 31, 2012·Acta Oncologica·Tsang-Wu LiuSiew Tzuh Tang
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperDana S Wollins
Sep 2, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sang Hyuck KimJong-Hyock Park
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P RochigneuxL Morin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

The Journal of the Oklahoma State Medical Association
J A Montero
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Takeshi HanagiriKosei Yasumoto
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Shin Hye YooDae Seog Heo
© 2022 Meta ULC. All rights reserved